10x Genomics advanced its push from research platforms into clinical diagnostics by detailing plans for a CLIA-certified laboratory at its Pleasanton, California headquarters. The lab is expected to open next year, supporting clinical assay validation and enabling 10x to scale collaborations that use its single-cell sequencing and spatial biology platforms. The company also cited a multi-year collaboration with Cleveland Clinic focused on bladder cancer biomarkers, using patient samples to correlate single-cell and spatial findings with therapeutic outcomes across immunotherapies and antibody-drug conjugates. Separately, Parhelia Biosciences and Sirona Dx announced a partnership to improve scalability and reproducibility for spatial biology workflows. Parhelia will contribute its Spatial Station automation platform, while Sirona Dx will help tailor workflows across clients for discovery through clinical development.